OpenFilings

Vistagen Therapeutics, Inc.

Form10-Q

Report Period2024-12-31

Date Filed2025-02-13

Time Filed17:25:15

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-Q
EX-31.1
EX-31.2
EX-32
Filing on SEC Edgar